Darwin Advisors, LLC Xenetic Biosciences, Inc. Transaction History

Darwin Advisors, LLC

  • $197 Million
  • Q2 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 06, 2020
SELL
$0.71 - $1.31 $7 - $14
-11 Closed
0 $0
Q1 2020

May 01, 2020
BUY
$0.49 - $1.69 $5 - $18
11 New
11 $0

About Xenetic Biosciences, Inc.

XBIO Quotes by TradingView
  • Ticker XBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 15,166,600
  • Market Cap $64.6M
  • Description
  • Xenetic Biosciences, Inc., a biopharmaceutical company, focuses on advancing XCART, a personalized chimeric antigen receptor T cell (CAR T) platform technology engineered to target patient-specific tumor neoantigens. The company engages in the discovery, research, and development of biologic drugs and oncology therapeutics. It advances cell-base...
More about XBIO
Track This Portfolio

Track Darwin Advisors, LLC Portfolio

Follow Darwin Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Darwin Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Darwin Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email